ADAP
Adaptimmune Therapeutics
ADAP
ADAP
59 hedge funds and large institutions have $274M invested in Adaptimmune Therapeutics in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 14 increasing their positions, 20 reducing their positions, and 10 closing their positions.
Holders
59
Holders Change
-9
Holders Change %
-13.24%
% of All Funds
1.28%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
14
Reduced
20
Closed
10
Calls
$85K
Puts
–
Net Calls
+$85K
Net Calls Change
+$120K